Zurich Cantonal Bank
SGNT

Zurich Cantonal Bank’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Zurich Cantonal Bank’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-309
Closed -$5K – 2594
2016
Q2 		$5K Hold
309
– – ﹤0.01% 2507
2016
Q1 		$4K Hold
309
– – ﹤0.01% 2540
2015
Q4 		$5K Hold
309
– – ﹤0.01% 2530
2015
Q3 		$5K Buy
+309
New +$6.68K ﹤0.01% 2410
2014
Q1 		– Sell
-150,000
Closed -$3.81M – 1005
2013
Q4 		$3.81M Buy
+150,000
New +$3.39M 0.12% 186

Zurich Cantonal Bank's SGNT Position: Q3 2016 in Review

Zurich Cantonal Bank sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 309 shares — an estimated $5K sold.

Zurich Cantonal Bank first reported a position in SGNT in Q4 2013 and held it in 5 quarters. The position peaked at $3.81M in Q4 2013. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Zurich Cantonal Bank reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Zurich Cantonal Bank sold 309 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $5K.
  • Zurich Cantonal Bank first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 5 quarters.
  • Zurich Cantonal Bank's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $3.81M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Zurich Cantonal Bank's 13F filing for Q3 2016, filed 14 Nov 2016.